Next Article in Journal
An Overview of Biotransformation for the Sustainability of Sweet-Tasting Proteins as Natural Sugar Replacers
Previous Article in Journal
Eugenol Ester Derivatives: Synthesis, Insecticidal Activity and Computational Studies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Palladium Cyclometallated Compounds: Evaluation of Their Catalytic Activity in Cross-Coupling Reactions †

by
Marcos Rúa-Sueiro
*,
Paula Munín-Cruz
,
Sara Bermúdez-Fernández
and
José M. Vila
Department of Inorganic Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Avda. das Ciencias s/n, 15782 Santiago de Compostela, Spain
*
Author to whom correspondence should be addressed.
Presented at the 2nd International Electronic Conference on Catalysis Sciences—A Celebration of Catalysts 10th Anniversary, 15–30 October 2021; Available online: https://eccs2021.sciforum.net/.
Chem. Proc. 2022, 6(1), 10; https://doi.org/10.3390/ECCS2021-11034
Published: 12 July 2022

Abstract

:
Catalysts are substances that can increase the speed of a chemical reaction and are often used in the chemical industry. Palladium is one of the most widely used metal centers in metal-based catalysts, and a lot of palladium complexes have been extensively used in many reactions, particularly in cross-coupling reactions with a carbon−carbon bond formation. All their possible applications as catalysts, along with their uses in biological assays as anticancer agents, make these family of complexes very interesting and highly studied, allowing the modification of the ligands around the metal and the extreme modulation of their properties. Herein we report the synthesis of several palladium cyclometallated compounds with thiosemicarbazone ligands and bis(diphenylphosphino)methane (dppm). Additionally, we evaluate their catalytic activity in a Suzuki−Miyaura cross-coupling reaction, using 4-bromoacetophenone and phenylboronic acid as reagents and following the reaction with 1H-NMR spectroscopy. A final comparison between the catalytic conversions and the complexes allows us to propose the best structure for a catalytic purpose in these conditions.

1. Introduction

The chemistry of transition metals has been extensively studied over the years [1,2]. The high number of different metals and the ligands that can coordinate around them make this kind of complex very extensive with different properties and applications in coordinative and organometallic chemistry.
Among all these metals, palladium is one of the most interesting. Its coordinative ability to many donor atoms [3,4,5], including carbon atoms to synthesized cyclometallated compounds [6,7,8], makes this metal an excellent choice. The square-planar geometry facilitates the coordination of multidentate ligands [9,10], creating very stable complexes.
Cyclometallated compounds with palladium, using thiosemicarbazone ligands, are reported in this research work [11,12,13,14,15]. We show the catalytic activity for these ligands with different metal complexes [16]. The catalytic activity of all species synthesized is discussed for the Suzuki−Miyaura’s reaction.

2. Experimental

The reactions to obtain the thiosemicarbazone ligands, tetranuclear compounds with palladium and reaction of these compounds with dppm were carried out following the procedure we reported earlier [17].

Synthesis of Homodinuclear Compounds (1012)

Compounds 79 (15 mg) and bis(benzonitrile)palladium (II) chloride (quantities shown in Table 1) were added under nitrogen in a deoxygenated solution of acetone (Scheme 1). After stirring for 24 h at room temperature, the solvent was removed under a reduced pressure, and the residue was treated with dichloromethane-hexane, centrifugated and dried under a vacuum.

3. Results and Discussion

The previous synthetic route is shown in Scheme A1 and NMR spectra are included in Figure A1 and Figure A2. The general procedures and characterization data are listed in Appendix B.
The comparison of the 1H NMR spectra between the dinuclear compounds (10-12) with the previous ones (79) does not show very significant changes. The most remarkable one is the high field shift of the PCH2P protons, due to the second metal coordination to the free phosphorus atom. This fact is supported with the 31P-{1H} NMR spectrum of 10 because two doublets appear downfield, caused by the coordination of the two phosphorus atoms to different palladium metal centers (as shown in Figure 1).

4. Catalytic Conversion

The Suzuki−Miyaura reaction was carried out using 4-bromoacetophenone and phenylboronic acid as reagents (see Scheme 2). Aliquots were taken during the reaction, and results were monitored with 1H NMR spectroscopy as shown in Figure 2.
Conversion results are shown in Table 2 for all reactions.
The results show that the dinuclear compounds are extremely good catalysts, probably due to the Pd−Cl bond. The bond lability allows these compounds to be very effective in these conditions.
Compounds 49 show poor catalytic activity in these conditions, especially compared to their homodinuclear counterparts.

5. Conclusions

  • Homodinuclear compounds were satisfactorily synthesized, showing a six-membered ring with two palladium atoms.
  • NMR spectra of compounds 1012 confirm the product structure.
  • Catalytic assays were performed for compounds 412.
  • Catalytic results show that the dinuclear compounds are better catalysts for the Suzuki−Miyaura reaction.

Author Contributions

Conceptualization, M.R.-S. and P.M.-C.; methodology, M.R.-S. and S.B.-F.; software, M.R.-S.; validation, M.R.-S., P.M.-C. and S.B.-F.; formal analysis, M.R.-S.; investigation, M.R.-S. and P.M.-C.; resources, J.M.V.; writing—original draft preparation, M.R.-S. and J.M.V.; writing—review and editing, M.R.-S.; visualization, M.R.-S. and P.M.-C.; supervision, J.M.V.; project administration, M.R.-S. and J.M.V.; funding acquisition, J.M.V.. All authors have read and agreed to the published version of the manuscript.

Acknowledgments

The authors thank funding from Xunta de Galicia (Galicia, Spain) under the Grupos de Referencia program (GRC 2019/014).

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Scheme A1. Synthetic route of compounds 19.
Scheme A1. Synthetic route of compounds 19.
Chemproc 06 00010 sch0a3
Figure A1. 1H spectra in DMSO-d6 of compound 3 (a) and 5 (b).
Figure A1. 1H spectra in DMSO-d6 of compound 3 (a) and 5 (b).
Chemproc 06 00010 g0a1
Figure A2. NMR spectra of compound 8 in MeCOMe-d6. (a) 1H NMR spectrum and (b) 31P─{1H} NMR spectrum.
Figure A2. NMR spectra of compound 8 in MeCOMe-d6. (a) 1H NMR spectrum and (b) 31P─{1H} NMR spectrum.
Chemproc 06 00010 g0a2

Appendix B

Elemental analyses were performed with a Thermo Finnigan analyzer, model Flash 1112. IR spectra were recorded on a Jasco model FT/IR-4600 spectrophotometer equipped with an ATR model ATR-PRO ONE. 1H NMR spectra and 31P-{1H} NMR spectra were recorded on a Varian Inova 400 spectrometer operating at 400.14 MHz (1H NMR) and 161.91 MHz (31P-{1H} NMR), using 5 mm o.d. tubes. Chemical shifts, in ppm, are reported downfield relative to TMS using the solvent signal as a reference (DMSO-d6 = 2.50, MeCOMe-d6 = 2.05, CDCl3 = 7.26) in 1H NMR spectra and relative to external H3PO4 (85%) in 31P-{1H} NMR. Coupling constants are reported in Hz.
Compound 1
Yield: 535.3 mg, 90%. Anal. Theorical: C: 53.8, H: 5.9, N: 18.8, S: 14.4%; found: C: 52.7, H: 5.9, N: 18.1, S: 15.0%; C10H13N3OS (223.29 g/mol); IR (cm−1): ν(C=N) 1606, ṽ(C=S) 826. 1H NMR (400 MHz, DMSO-d6, δ/ppm): 10.11 (s, 1H, NNH), 8.20 (s, 1H, NH2), 7.88 (d, 1H, H2/H6, N = 8.8), 7.85 (s, 1H, NH2), 6.92 (d, 2H, H3/H5, N = 8.8), 3.78 (s, 3H, OMe), 2.26 (s, 3H, MeC=N).
Compound 2
Yield: 619.5 mg, 98%. Anal. Theorical: C: 55.7, H: 6.4, N: 17.7, S: 13.5%; found: C: 55.6, H: 6.6, N: 17.5, S: 13.4%; C11H15N3OS (237.32 g/mol); IR (cm−1): ν(C=N) 1607, ν(C=S) 836. 1H NMR (400 MHz, DMSO-d6, δ/ppm, J/Hz): 10.11 (s, 1H, NNH), 8.39 (q, 1H, NHMe, 3J = 4.5), 7.89 (d, 2H, H2/H6, N = 8.8), 6.94 (d, 2H, H3/H5, N = 8.8), 3.79 (s, 3H, OMe), 3.03 (d, 3H, NHMe, 3J = 4.6), 2.26 (s, 3H, MeC=N).
Compound 3
Yield: 589.1 mg, 88%. Anal. Theorical: C: 57.3, H: 6.8, N: 16.7, S: 12.8%; found: C: 57.4, H: 6.8, N: 16.7, S: 13.0%; C12H17N3OS (251.35 g/mol); IR (cm−1): ν(C=N) 1595, ν(C=S) 829. 1H NMR (400 MHz, DMSO-d6, δ/ppm, J/Hz): 10.03 (s, 1H, NNH), 8.43 (t, 1H, NHEt, 3J = 5.7), 7.88 (d, 2H, H2/H6, N = 8.8), 6.94 (d, 2H, H3/H5, N = 8.8), 3.79 (s, 3H, OMe), 3.61 (m, 2H, NHCH2CH3), 2.26 (s, 3H, MeC=N), 1.15 (t, 3H, NHCH2CH3, 3J = 7.1).
Compound 4
Yield: 112.9 mg, 75%. Anal. Theorical: C: 36.7, H: 3.4, N: 12.8, S: 9.8%; found: C: 36.7, H: 3.6, N: 12.7, S: 9.6%; C40H44N12O4Pd4S4 (1310.79 g/mol); IR (cm−1): ν(C=N) 1577. 1H NMR (400 MHz, DMSO-d6, δ/ppm, J/Hz): 6.93 (d, 1H, H5, 4J = 1.9), 6.53 (m, 3H, H2/NH2), 6.30 (dd, 1H, H3, 3J = 8.3, 4J = 1.9), 3.75 (s, 3H, OMe), 1.76 (s, 3H, MeC=N).
Compound 5
Yield: 122.5 mg, 78%. Anal. Theorical: C: 38.7, H: 3.8, N: 12.3, S: 9.4%; found: C: 38.6, H: 3.9, N: 12.0, S: 9.1%; C44H52N12O4Pd4S4 (1366.90 g/mol); IR (cm−1): ν(C=N) 1571. 1H NMR (400 MHz, DMSO-d6, δ/ppm, J/Hz): 7.09 (d, 1H, H5, 4J = 2.6), 6.60 (d, 1H, H2, 3J = 8.4), 6.36 (dd, 1H, H3, 3J = 8.4, 4J = 2.6), 4.95 (q, 1H, NHMe, 3J = 4.8), 3.84 (s, 3H, OMe), 2.94 (d, 3H, NHMe, 3J = 4.9), 1.81 (s, 3H, MeC=N).
Compound 6
Yield: 140.6 mg, 86%. Anal. Theorical: C: 40.5, H: 4.3, N: 11.8, S: 9.0%; found: C: 40.5, H: 4.4, N: 11.9, S: 8.9%; C48H60N12O4Pd4S4 (1423.01 g/mol); IR (cm−1): ν(C=N) 1572. 1H NMR (400 MHz, DMSO-d6, δ/ppm, J/Hz): 7.18 (d, 1H, H5, 4J = 2.5), 6.81 (m, 1H, NHEt), 6.76 (d, 1H, H2, 3J = 8.4), 6.55 (dd, 1H, H3, 3J = 8.4, 4J = 2.5), 4.00 (s, 3H, OMe), 2.75 (m, 2H, NHCH2CH3), 2.01 (s, 3H, MeC=N), 1.30 (t, 3H, NHCH2CH3, 3J = 7.0).
Compound 7
Yield: 71.7 mg, 66%. Anal. Theorical: C: 59.0, H: 4.7, N: 5.9, S: 4.5%; found: C: 59.0, H: 4.9, N: 5.6, S: 4.3 %; C35H33N3OP2PdS (712.10 g/mol); IR (cm−1): ν(C=N) 1575. 1H NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 7.94–7.15 (m, 20H, HAr), 6.89 (d, 1H, H2, 3J = 8.4), 6.25 (d, 1H, H3, 3J = 8.2), 5.87 (m, 1H, H5), 5.73 (s, 2H, NH2) 3.39 (m, 2H, PCH2P), 3.14 (s, 3H, OMe), 2.18 (s, 3H, MeC=N). 31P-{1H} NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 28.20 (d, PA, 2J = 87.9), -23.55 (d, PB, 2J = 87.9).
Compound 8
Yield: 79.7 mg, 75%. Anal. Theorical: C: 59.6, H: 4.9, N: 5.8, S: 4.4%; found: C: 59.3, H: 4.8, N: 5.6, S: 4.3%; C36H35N3OP2PdS (726.12 g/mol); IR (cm−1): ν(C=N) 1578. 1H NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 7.87–7.18 (m, 20H, HAr), 6.93 (d, 1H, H2, 3J = 8.4), 6.28 (dd, 1H, H3, 3J = 8.4, 4J = 2.3), 5.89 (m, 1H, H5), 3.40 (m, 2H, PCH2P), 3.14 (s, 3H, OMe), 2.91 (d, 3H, NHMe, 3J = 4.8), 2.35 (s, 3H, MeC=N). 31P-{1H} NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 28.53 (d, PA, 2J = 87.4), -23.58 (d, PB, 2J = 87.4).
Compound 9
Yield: 74.9 mg, 72%. Anal. Theorical: C: 60.0, H: 5.0, N: 5.7, S: 4.3%; found: C: 60.2, H: 5.1, N: 5.3, S: 4.2%; C37H37N3OP2PdS (740.15 g/mol); IR (cm−1): ν(C=N) 1577. 1H NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 7.91–7.14 (m, 20H, HAr), 6.92 (d, 1H, H2, 3J = 8.4), 6.27 (d, 1H, H3, 3J = 8.4), 5.89 (m, 1H, H5), 3.40 (m, 5H, PCH2P/NHCH2CH3), 3.14 (s, 3H, OMe), 2.23 (s, 3H, MeC=N), 1.22 (t, 3H, NHCH2CH3, 3J = 7.4). 31P-{1H} NMR (400 MHz, MeCOMe-d6, δ/ppm, J/Hz): 28.57 (d, PA, 2J = 86.7), -23.57 (d, PB, 2J = 86.7).
Compound 10
Yield: 11.2 mg, 60%. Anal. Theorical: C: 47.3, H: 3.7, N: 4.7, S: 3.6 %; found: C: 46.2, H: 3.7, N: 4.3, S: 3.4%; C35H33Cl2N3OP2Pd2S (889.41 g/mol); IR (cm−1): ν(C=N) 1578. 1H NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 7.92–7.11 (m, 20H, HAr), 7.00 (d, 1H, H2, 3J = 8.0), 6.39 (d, 1H, H3, 3J = 8.1), 5.82 (m, 1H, H5), 5.28 (s, 2H, NH2), 3.12 (m, 5H, PCH2P/OMe), 2.36 (s, 3H, MeC=N). 31P-{1H} NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 21.87 (d, PA, 2J = 26.0), 16.10 (d, PB, 2J = 26.0).
Compound 11
Yield: 9.7 mg, 52%. Anal. Theorical: C: 47.9, H: 3.9, N: 4.7, S: 3.6%; found: C: 46.7, H: 3.6, N: 4.4, S: 3.3%; C36H35Cl2N3OP2Pd2S (903.44 g/mol); IR (cm−1): ν(C=N) 1573. 1H NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 7.94–7.15 (m, 20H, HAr), 6.92 (d, 1H, H2, 3J = 8.0), 6.43 (d, 1H, H3, 3J = 8.0), 5.87 (m, 1H, H5), 4.89 (m, 1H, NHMe), 3.16 (m, 5H, PCH2P/OMe), 3.03 (m, 3H, NHMe), 2.45 (s, 3H, MeC=N). 31P-{1H} NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 21.69 (d, PA, 2J = 26.9), 15.71 (d, PB, 2J = 26.9).
Compound 12
Yield: 10.2 mg, 55%. Anal. Theorical: C: 48.4, H: 4.1, N: 4.6, S: 3.5%; found: C: 46.5, H: 3.7, N: 4.4, S: 3.4%; C37H37Cl2N3OP2Pd2S (917.47 g/mol); IR (cm−1): ν(C=N) 1576. 1H NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 7.92–7.10 (m, 20H, HAr), 6.99 (d, 1H, H2, 3J = 7.8), 6.38 (d, 1H, H3, 3J = 7.8), 5.83 (m, 1H, H5), 5.17 (m, 1H, NHEt), 3.43 (m, 2H, NHCH2CH3), 3.12 (m, 5H, PCH2P/OMe), 2.37 (s, 3H, MeC=N), 1.17 (m, 3H, NHCH2CH3). 31P-{1H} NMR (400 MHz, CDCl3, δ/ppm, J/Hz): 21.70 (d, PA, 2J = 26.7), 15.70 (d, PB, 2J = 26.7).

References

  1. Zaera, F. An organometallic guide to the chemistry of hydrocarbon moieties on transition metal surfaces. Chem. Rev. 1995, 95, 2651–2693. [Google Scholar] [CrossRef]
  2. Zaki, M.; Hairat, S.; Aazam, E.S. Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: Starting from the classical paradigm to targeting multiple strategies. RSC Adv. 2019, 9, 3239–3278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Estevan, F.; Ibáñez, S.; Ofori, A.; Hirva, P.; Sanaú, M.; Úbeda, M.A. Benzoato and Thiobenzoato Ligands in the Synthesis of Dinuclear Palladium (III) and-(II) Compounds: Stability and Catalytic Applications. Eur. J. Inorg. Chem. 2015, 2015, 2822–2832. [Google Scholar] [CrossRef]
  4. Petrović, V.P.; Živanović, M.N.; Simijonović, D.; Đorović, J.; Petrović, Z.D.; Marković, S.D. Chelate N,O-palladium(ii) complexes: Synthesis, characterization and biological activity. RSC Adv. 2015, 5, 86274–86281. [Google Scholar] [CrossRef]
  5. Ayyannan, G.; Veerasamy, P.; Mohanraj, M.; Raja, G.; Manimaran, A.; Velusamy, M.; Bhuvanesh, N.; Nandhakumar, R.; Jayabalakrishnan, C. Biological evaluation of organometallic palladium(II) complexes containing 4-hydroxybenzoic acid (3-ethoxy-2-hydroxybenzylidene)hydrazide: Synthesis, structure, DNA/protein binding, antioxidant activity and cytotoxicity. Appl. Organomet. Chem. 2017, 31, e3599. [Google Scholar] [CrossRef]
  6. Fernández-Figueiras, A.; Lucio-Martínez, F.; Munín-Cruz, P.; Polo-Ces, P.; Reigosa, F.; Adams, H.; Pereira, M.T.; Vila, J.M. Palladium iminophosphorane complexes: The pre-cursors to the missing link in triphenylphosphane chalcogenide metallacycles. Dalton Trans. 2018, 47, 15801–15807. [Google Scholar] [CrossRef] [PubMed]
  7. Liu, J.-K.; Gong, J.-F.; Song, M.-P. Chiral palladium pincer complexes for asymmetric catalytic reactions. Org. Biomol. Chem. 2019, 17, 6069–6098. [Google Scholar] [CrossRef] [PubMed]
  8. Munin-Cruz, P.; Reigosa, F.; Rúa-Sueiro, M.; Ortigueira, J.M.; Pereira, M.T.; Vila, J.M. Chemistry of Tetradentate [C,N : C,N] Iminophosphorane Palladacycles: Preparation, Reactivity and Theoretical Calculations. ChemistryOpen 2020, 9, 1190–1194. [Google Scholar] [CrossRef] [PubMed]
  9. Ojwach, S.O.; Guzei, I.A.; Darkwa, J.; Mapolie, S.F. Palladium complexes of multidentate pyrazolylmethyl pyridine ligands: Synthesis, structures and phenylacetylene polymerization. Polyhedron 2007, 26, 851–861. [Google Scholar] [CrossRef]
  10. Ashida, Y.; Manabe, Y.; Yoshioka, S.; Yoneda, T.; Inokuma, Y. Control over coordination self-assembly of flexible, multidentate ligands by stepwise metal coordination of isopyrazole subunits. Dalton Trans. 2019, 48, 818–822. [Google Scholar] [CrossRef]
  11. Adrio, L.; Antelo, J.M.; Fernández, J.J.; Hii, K.K.M.; Pereira, M.T.; Vila, J.M. [Pd {2-CH2-5-MeC6H3C (H) NNC (S) NHEt}] 3: An unprecedented trinuclear cyclometallated palladium (II) cluster through induced flexibility in the metallated ring. J. Organomet. Chem. 2009, 694, 747–751. [Google Scholar] [CrossRef]
  12. Chellan, P.; Nasser, S.; Vivas, L.; Chibale, K.; Smith, G.S. Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity. J. Organomet. Chem. 2010, 695, 2225–2232. [Google Scholar] [CrossRef]
  13. Antelo, J.M.; Adrio, L.; Pereira, M.T.; Ortigueira, J.M.; Fernandez, A.; Vila, J.M. Synthesis and Structural Characterization of New Bimetallic [C,N,S] Palladacycles with Mixed Bridging [P,P] and Chelating [P,P] or [P,N] Phosphane Ligands. Eur. J. Inorg. Chem. 2011, 3, 368–376. [Google Scholar] [CrossRef]
  14. Antelo, J.M.; Adrio, L.; Bermúdez, B.; Martínez, J.; Pereira, M.T.; Ortigueira, J.M.; López-Torres, M.; Vila, J.M. Spectroscopic and solid state characterization of bimetallic terdentate [C, N, S] thiosemicarbazone Palladium (II) metallacycles with bridging and chelating [P, P] diphosphine ligands. J. Organomet. Chem. 2013, 740, 83–91. [Google Scholar] [CrossRef]
  15. Pereira, M.T.; Antelo, J.M.; Adrio, L.A.; Martinez, J.; Ortigueira, J.M.; Lopez-Torres, M.; Vila, J.M. Novel Bidentate [N,S] Palladacycle Metalloligands. 1H-15N HMBC as a Decisive NMR Technique for the Structural Characterization of Palladium-Rhodium and Palladium-Palladium Bimetallic Complexes. Organometallics 2014, 33, 3265–3274. [Google Scholar] [CrossRef]
  16. Kostas, I.D.; Steele, B.R. Thiosemicarbazone complexes of transition metals as catalysts for cross-coupling reactions. Catalysts 2020, 10, 1107. [Google Scholar] [CrossRef]
  17. Rúa-Sueiro, M.; Munin-Cruz, P.; Reigosa, F.; Vila, J.M.; Ortigueira, J.M. Synthesis and X-ray Diffraction Study of thiosemicarbazone Palladacycles with dppm. Proceedings 2020, 62, 13. [Google Scholar]
Scheme 1. Formation of dinuclear compounds.
Scheme 1. Formation of dinuclear compounds.
Chemproc 06 00010 sch001
Figure 1. NMR spectra of compound 10 in CDCl3. (a) 1H NMR spectrum and (b) 31P-{1H} NMR spectrum.
Figure 1. NMR spectra of compound 10 in CDCl3. (a) 1H NMR spectrum and (b) 31P-{1H} NMR spectrum.
Chemproc 06 00010 g001
Scheme 2. Suzuki−Miyaura’s reaction scheme.
Scheme 2. Suzuki−Miyaura’s reaction scheme.
Chemproc 06 00010 sch002
Figure 2. Example of a 33% conversion rate for a catalytic reaction.
Figure 2. Example of a 33% conversion rate for a catalytic reaction.
Chemproc 06 00010 g002
Table 1. Summary of yields and colors of complexes 1012.
Table 1. Summary of yields and colors of complexes 1012.
CompoundReagentR(PhCN)2PdCl2/mgYield/%Appearance
107H8.160Red solid
118Me7.952Orange solid
129Et7.855Orange solid
Table 2. Results obtained for catalytic assays.
Table 2. Results obtained for catalytic assays.
CompoundReaction Time/hConversion/%
4240
52415
62418
72412
82417
92422
10245
889
2498
11236
874
2497
12243
865
2496
Aliquots in 49 reactions are not listed due to the low conversion. Reactions were carried out using 4-bromoacetophenone (0.2 mmol), phenylboronic acid (1.2 eq.), catalyst (1 mol%) and potassium carbonate (2 eq.) in TFH:H2O (2:1) at 80 °C. Conversion was determined by 1H NMR spectroscopy.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rúa-Sueiro, M.; Munín-Cruz, P.; Bermúdez-Fernández, S.; Vila, J.M. Palladium Cyclometallated Compounds: Evaluation of Their Catalytic Activity in Cross-Coupling Reactions. Chem. Proc. 2022, 6, 10. https://doi.org/10.3390/ECCS2021-11034

AMA Style

Rúa-Sueiro M, Munín-Cruz P, Bermúdez-Fernández S, Vila JM. Palladium Cyclometallated Compounds: Evaluation of Their Catalytic Activity in Cross-Coupling Reactions. Chemistry Proceedings. 2022; 6(1):10. https://doi.org/10.3390/ECCS2021-11034

Chicago/Turabian Style

Rúa-Sueiro, Marcos, Paula Munín-Cruz, Sara Bermúdez-Fernández, and José M. Vila. 2022. "Palladium Cyclometallated Compounds: Evaluation of Their Catalytic Activity in Cross-Coupling Reactions" Chemistry Proceedings 6, no. 1: 10. https://doi.org/10.3390/ECCS2021-11034

Article Metrics

Back to TopTop